Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

IBIO

iBio (IBIO)

iBio Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:IBIO
DataHoraFonteTítuloCódigoCompanhia
20/09/202417:14Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:IBIOiBio Inc
20/09/202417:07Edgar (US Regulatory)Form 8-K - Current reportAMEX:IBIOiBio Inc
20/09/202417:05GlobeNewswire Inc.iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate UpdateAMEX:IBIOiBio Inc
03/09/202408:00GlobeNewswire Inc.iBio to Participate in Upcoming Investor ConferencesAMEX:IBIOiBio Inc
14/08/202418:24Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:IBIOiBio Inc
12/08/202417:30GlobeNewswire Inc.iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business DevelopmentAMEX:IBIOiBio Inc
07/08/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:IBIOiBio Inc
06/08/202418:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:IBIOiBio Inc
25/07/202418:05Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:IBIOiBio Inc
03/06/202408:00GlobeNewswire Inc.iBio Closes Sale of Manufacturing Facility in TexasAMEX:IBIOiBio Inc
13/05/202417:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:IBIOiBio Inc
13/05/202417:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:IBIOiBio Inc
13/05/202417:05GlobeNewswire Inc.iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate UpdateAMEX:IBIOiBio Inc
27/03/202408:00GlobeNewswire Inc.iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic DiseasesAMEX:IBIOiBio Inc
26/03/202420:35GlobeNewswire Inc.iBio Announces $15.0 Million Private PlacementAMEX:IBIOiBio Inc
26/02/202409:45GlobeNewswire Inc.iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to OtsukaAMEX:IBIOiBio Inc
16/01/202410:15GlobeNewswire Inc.iBio Announces Participation in 23rd Annual PepTalk ConferenceAMEX:IBIOiBio Inc
10/01/202415:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:IBIOiBio Inc
04/01/202410:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:IBIOiBio Inc
26/12/202309:15GlobeNewswire Inc.iBio Amends and Extends Maturity of Credit AgreementAMEX:IBIOiBio Inc
06/12/202310:59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:IBIOiBio Inc
05/12/202310:00GlobeNewswire Inc.iBio, Inc. Announces Pricing of $4.5 Million Public OfferingAMEX:IBIOiBio Inc
30/11/202310:55Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:IBIOiBio Inc
27/11/202319:20GlobeNewswire Inc.iBio Announces Reverse Stock SplitAMEX:IBIOiBio Inc
01/11/202309:24GlobeNewswire Inc.iBio Further Expands Tech Stack with ShieldTx™; Enhances Immuno-Oncology Development Pipeline with Conditionally Activated MUC16xCD3 BispecificAMEX:IBIOiBio Inc
27/10/202317:29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:IBIOiBio Inc
26/10/202309:22Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:IBIOiBio Inc
26/10/202309:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:IBIOiBio Inc
16/10/202317:59Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:IBIOiBio Inc
10/10/202309:00GlobeNewswire Inc.iBio to Highlight Technology for Advancing Discovery of Bispecifics at Festival of BiologicsAMEX:IBIOiBio Inc
 Apresentando as notícias mais relevantes sobre:AMEX:IBIO

Seu Histórico Recente

Delayed Upgrade Clock